Caribou Biosciences, Inc. (CRBU) vs Tenaya Therapeutics, Inc. (TNYA)

Caribou Biosciences, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Tenaya Therapeutics, Inc. are of similar size ($139.0M and $134.0M). Tenaya Therapeutics, Inc. has the higher net margin (0.00% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Caribou Biosciences, Inc. leads on 7 and Tenaya Therapeutics, Inc. on 5.

Valuation

Metric CRBU TNYA Biotechnology median
P/E n/m n/m 7.88
P/S 12.58 n/m 11.47
P/B 1.29 1.91 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.39 n/m 10.73
Earnings yield (86.40%) (86.89%) (28.84%)
Free cash flow yield (105.20%) (39.62%) (23.03%)

Profitability

Metric CRBU TNYA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,090.90%) 0.00% 0.00%
Net margin (1,030.42%) 0.00% 0.00%
Free cash flow margin (1,323.30%) 0.00% 0.00%
Return on equity (78.27%) (121.86%) (57.72%)
Return on assets (56.87%) (95.61%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU TNYA Biotechnology median
Revenue growth (TTM) 10.02% — 5.64%
EPS growth (last fiscal year) 3.64% 54.96% —
Revenue growth, 5-year CAGR (2.03%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU TNYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.49 4.52 4.73
Net debt to EBITDA 0.96 1.19 0.96

Dividend

Metric CRBU TNYA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRBU TNYA Biotechnology median
Market cap 134.01m 139.02m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack